Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors

Part of paid clinical trials in Tallahassee, Florida.

Sponsor
University of Oklahoma
Study ID
NCT06651359
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
MALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Surveys for Quality of Life — BEHAVIORAL
    This group will take scheduled electronic surveys (at the beginning of the study, months 3, 6, 9, and 12) to assess the overall impact of prostate cancer on quality of life (QoL).
  • Surveys and mHealth App access — BEHAVIORAL
    This group will take scheduled electronic surveys (at the beginning of the study, months 3, 6, 9, and 12) to assess the overall impact of prostate cancer on quality of life (QoL). Additionally, they will have a brief "initial study visit," in-person or virtually, to review the app use. This arm of participants will use the mobile application at home for 12 months. During the first 12 weeks, the application will send daily surveys about symptoms, dietary and physical activities, weekly surveys about their mood, and an assessment of their overall QoL every 3 months. The app will provide tailored educational content, including short readings, videos, and audio recordings, to help users learn more about managing symptoms and improving their functioning. After 12 months of app use, an interview will be conducted to gather feedback about their experiences with the app. The information collected from these interviews will be analyzed to further enhance and improve the app's functionality.

Study Details

The goal of this clinical trial is to ensure that the mobile health application for Black patients with prostate cancer (either actively undergoing treatment or survivors) is usable and acceptable to patients, get feedback about how to improve the app and assess its usefulness in examining their quality of life.

Key Dates

Start date
Aug 24, 2025
Status verified
Mar 2026
Primary completion
Oct 31, 2029
Completion
Nov 30, 2030

Study Design

Enrollment
248 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Other: Control group
    Participants in this arm will be eligible Black men who have prostate cancer and are either currently undergoing treatment or are cancer survivors.
  • Experimental: Intervention group
    Participants in this arm will be eligible Black men who have prostate cancer and are either currently undergoing treatment or are cancer survivors, who are given access to the mHealth app for this study.

Primary Outcome Measure

Overall Quality of Life (QoL) assessment in Black men with prostate cancer [ Time Frame: 12 months ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Florida State UniversityTallahasseeFlorida32306-4310
Sabrina Dickey, PhD, RN
Sabrina Dickey, PhD, RN (SUB_INVESTIGATOR)
Georgia College & State UniversityMilledgevilleGeorgia31061
Ernie Kaninjing, DrPH
Ernie Kaninjing, DrPH (SUB_INVESTIGATOR)
University of Oklahoma HSCOklahoma CityOklahoma73104
Motolani Adedipe, PhD, DPh, MS
[email protected]
Motolani Adedipe (PRINCIPAL_INVESTIGATOR)

Find similar trials in Tallahassee, FL

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
Florida State University· Tallahassee, FLGeorgia College & State University· Milledgeville, GAUniversity of Oklahoma HSC· Oklahoma City, OK

Related Studies